Cerebral proton magnetic resonance spectroscopic imaging in a neonate with tuberous sclerosis

F. Groenendaal, L. C. Meiners, R. Gooskens, L. S. De Vries*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

Abstract

On the basis of detection of cardiac tumours and an intracerebral subependymal mass, the diagnosis of tuberous sclerosis was made in a fullterm neonate. To evaluate cerebral metabolism cerebral mass proton magnetic resonance spectroscopic imaging (1H-MRSI) was performed. A local decrease in N-acetyl-aspartate (NAA), and an increase in choline signals were found. Lactate could neither be demonstrated in the subependymal nodule, nor in the surrounding tissue, thereby rendering the possibility of a high-grade malignant tumour less likely. No major changes were found at 3 and 6 months of age. The present study demonstrates, that 1H-MRSI may be helpful in metabolic evaluation of cerebral masses in patients with tuberous sclerosis.

Original languageEnglish
Pages (from-to)154-157
Number of pages4
JournalNeuropediatrics
Volume25
Issue number3
DOIs
Publication statusPublished - 1 Jan 1994

Keywords

  • Hamartoma
  • Proton magnetic resonance spectroscopic imaging
  • Subependymal nodule
  • Tuberous sclerosis

Fingerprint

Dive into the research topics of 'Cerebral proton magnetic resonance spectroscopic imaging in a neonate with tuberous sclerosis'. Together they form a unique fingerprint.

Cite this